SELVAS Healthcare KRX:208370KOSDAQ
셀바스헬스케어 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days0
Articles tracked0since Sep 11
In Q2 2026, SELVAS Healthcare reported revenue of ₩8.2bn, up 22.3% year on year, and operating profit of ₩372m. SELVAS Healthcare (셀바스헬스케어) appeared in 0 Korean news articles and 0 DART filings over the past seven days.
Filing signals Turnaround Screener
SELVAS Healthcare quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩8.2bn | +22.3% | ₩372m margin 4.5% | −₩8.7bn |
| Q1 2026 | ₩6.6bn | -8.8% | ₩669m margin 10.2% | ₩13.2bn |
| Q4 2025 derived | ₩10.2bn | +11.3% | −₩22m margin −0.2% | ₩3.6bn |
| Q3 2025 | ₩6.7bn | -22.0% | ₩541m margin 8.1% | ₩509m |
| Q2 2025 | ₩6.7bn | -6.6% | −₩1.0bn margin −15.4% | −₩456m |
| Q1 2025 | ₩7.2bn | +6.6% | ₩349m margin 4.8% | ₩194m |
| Q4 2024 derived | ₩9.2bn | +36.1% | ₩1.1bn margin 12.0% | ₩2.1bn |
| Q3 2024 | ₩8.6bn | +9.0% | ₩1.5bn margin 18.0% | ₩214m |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
SELVAS Healthcare top stories 2 weeks, by number of outlets
No story covered by multiple outlets in the past two weeks.
Latest SELVAS Healthcare news Korean headlines
No articles yet.